ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Quality Oncology Wins Pilot Contract For Cancer Management In Fla.

July 27, 2001

Fish Oil May Help Prevent Weight Loss In Cancer Patients

September 26, 2003

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

April 6, 1979

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

Increased Breast Density Can Lead to Higher Risk

August 26, 2011